IJGC

Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)
Anna Fagotti, Maria Gabriella Ferrandina, Giuseppe Vizzielli, Tina Pasciuto, Francesco Fanfani, Valerio Gallotta, Pasquale Alessandro Margariti, Vito Chiantera, Barbara Costantini, Salvatore Gueli Alletti, Francesco Cosentino, Giovanni Scambia

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1657-1664; DOI: 10.1136/ijgc-2020-001640
DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment
Michelle McMullen, Katherine Karakasis, Bienvenu Loembe, Emma Dean, Graem Parr, Amit M Oza

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1824-1828; DOI: 10.1136/ijgc-2020-001694
Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010)
Hua Tu, He Huang, Bingna Xian, Jibin Li, Ping Wang, Weidong Zhao, Xiaojun Chen, Xing Xie, Chunyan Wang, Beihua Kong, Jing Xiao, Ping Zhang, Jihong Liu

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1829-1833; DOI: 10.1136/ijgc-2020-001857
A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial)
Tommaso Grassi, Andrea Mariani, David Cibula, Pamela T Soliman, Vera J Suman, Amy L Weaver, Silvana Pedra Nobre, Britta Weigelt, Gretchen E Glaser, Serena Cappuccio, Nadeem R Abu-Rustum

International Journal of Gynecologic Cancer Oct 2020, 30 (10) 1627-1632; DOI: 10.1136/ijgc-2020-001698
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)
Isabelle Ray-Coquard, Helen Hatcher, Emmanuelle Bompas, Antonio Casado, Annekke Westermann, Nicolas Isambert, Paolo Giovanni Casali, Sarah Pratap, Daniel Stark, Claudia Valverde, Anjana Anand, Manon Huizing, Anne Floquet, Lars Lindner, Barbara Hermes, Beatrice Seddon, Corneel Coens, Robin Jones, Nick Reed

International Journal of Gynecologic Cancer Oct 2020, 30 (10) 1633-1637; DOI: 10.1136/ijgc-2020-001519
Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: an international survey of peri-operative practice
Geetu Prakash Bhandoria, Prashant Bhandarkar, Vijay Ahuja, Amita Maheshwari, Rupinder K Sekhon, Murat Gultekin, Ali Ayhan, Fuat Demirkiran, Ilker Kahramanoglu, Yee-Loi Louise Wan, Pawel Knapp, Jakub Dobroch, Andrzej Zmaczyński, Robert Jach, Gregg Nelson

International Journal of Gynecologic Cancer Oct 2020, 30 (10) 1471-1478; DOI: 10.1136/ijgc-2020-001683
Use of PROM during follow-up of patients with ovarian cancer: the PROMova study protocol
Anette Stolberg Kargo, Angela Coulter, Kristina Lindemann, Pernille Tine Jensen, Niels Henrik Hjøllund, Berit Jul Mosgaard, Karina Dahl Steffensen

International Journal of Gynecologic Cancer Sep 2020, 30 (9) 1444-1449; DOI: 10.1136/ijgc-2020-001528
Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE)
Roni Nitecki, Jose Alejandro Rauh-Hain, Alexander Melamed, Giovanni Scambia, Rene Pareja, Robert L Coleman, Pedro T Ramirez, Anna Fagotti

International Journal of Gynecologic Cancer Sep 2020, 30 (9) 1450-1454; DOI: 10.1136/ijgc-2020-001584
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician’s choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)
Natalie YL Ngoi, Valerie Heong, Samuel Ow, Wen Yee Chay, Hee Seung Kim, Chel Hun Choi, Geraldine Goss, Jeffrey C Goh, Bee Choo Tai, Diana GZ Lim, Nivashini Kaliaperumal, Veonice B Au, John E Connolly, Jae-Weon Kim, Michael Friedlander, Kidong Kim, David SP Tan

International Journal of Gynecologic Cancer Aug 2020, 30 (8) 1239-1242; DOI: 10.1136/ijgc-2020-001604
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study
Jyoti Mayadev, Ana T Nunes, Mary Li, Michelle Marcovitz, Mark C Lanasa, Bradley J Monk

International Journal of Gynecologic Cancer Jul 2020, 30 (7) 1065-1070; DOI: 10.1136/ijgc-2019-001135

Main menu

IJGC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

IJGC

Pages